Xiao, Jerry
McGill, Joseph R.
Nasir, Apsra
Lekan, Alexander
Johnson, Bailey
Wilkins, Devan J.
Pearson, Gray W.
Tanner, Kandice
Goodarzi, Hani
Glasgow, Eric
Schlegel, Richard
Agarwal, Seema http://orcid.org/0000-0002-8854-252X
Funding for this research was provided by:
National Institutes of Health (R01CA218670)
Article History
Received: 10 February 2022
Accepted: 9 May 2022
First Online: 26 May 2022
Declarations
:
: Animal experiments with zebrafish were approved by the Georgetown University Institutional Animal Care and Use Committee, Protocol #2017–0078.
: Not applicable.
: RS co-invented the Conditional Cell Reprogramming technology, which Georgetown University has patented and licensed to Propagenix. Currently, there are no annual royalty streams. All other authors declare no conflict of interest.